2022 annual financial data
Cue Biopharma 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,357.91%.
Operating income was -53,225,000 USD and net income was -53,010,000 USD.
Operating cash flow was -41,806,000 USD.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,245,000 USD
- Operating income
- -53,225,000 USD
- Net income
- -53,010,000 USD
- Operating cash flow
- -41,806,000 USD